<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980157</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-20601</org_study_id>
    <nct_id>NCT04980157</nct_id>
  </id_info>
  <brief_title>CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers</brief_title>
  <official_title>CARES-HCV: Promoting Concurrent Hepatitis C Virus Screening and Colorectal Cancer Screening Uptake Among Diverse Baby Boomers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to examine the efficacy of educational materials to promote&#xD;
      hepatitis C virus (HCV) screening and colorectal cancer (CRC) screening uptake among adults&#xD;
      born between 1945-1965.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Hepatitis C Virus (HCV) knowledge</measure>
    <time_frame>Day 1 &amp; Day 7</time_frame>
    <description>Participants will be interviewed regarding their HCV knowledge on Day 1 prior to receiving educational materials. They will be interviewed once again approximately one week after receiving educational materials.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Colorectal Cancer (CRC) knowledge</measure>
    <time_frame>Day 1 &amp; Day 7</time_frame>
    <description>Participants will be interviewed regarding their CRC knowledge on Day 1 prior to receiving educational materials. They will be interviewed once again approximately one week after receiving educational materials.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hepatitis C Virus Screening Status</measure>
    <time_frame>at 6 months</time_frame>
    <description>Data about participants' HCV screening status will be collected from Federally Qualified Health Care Center's (FQHC) 6 months after participants have received educational materials.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Colorectal Cancer Screening Status</measure>
    <time_frame>at 6 months</time_frame>
    <description>Data about participants' CRC screening status will be collected from Federally Qualified Health Care Center's (FQHC) 6 months after participants have received educational materials.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hepatitis C Virus Infection</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>All Participants</arm_group_label>
    <description>Patients born between 1945-1965 who have clinic visits at a partnering federally qualified health center.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CARES-HCV</intervention_name>
    <description>CARES-HCV is an educational intervention to promote both hepatitis c screening and colorectal cancer screening among diverse baby boomers in the area.</description>
    <arm_group_label>All Participants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients born between 1945-1965 up to age 75 who have clinic visits at a partnering&#xD;
        federally qualified health center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Born between 1945 and 1965 and up to age 75&#xD;
&#xD;
          -  No personal history of colorectal cancer (CRC) or current presumptive colorectal&#xD;
             cancer symptoms (e.g., unresolved rectal bleeding or abdominal pain/bloating)&#xD;
&#xD;
          -  No personal history of hepatitis C virus (HCV) or liver cancer&#xD;
&#xD;
          -  Able to read, write, speak, and understand English or Spanish&#xD;
&#xD;
          -  Not currently enrolled in another CRC screening or a HCV screening study&#xD;
&#xD;
          -  At average risk for CRC (that is, no hereditary CRC syndromes such as lower&#xD;
             gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no&#xD;
             strong family history of CRC)&#xD;
&#xD;
          -  Not currently up-to date with CRC screenings&#xD;
&#xD;
          -  Not having previously completed HCV screening&#xD;
&#xD;
          -  Able and willing to complete a phone interview&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>56 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon M Christy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clement K Gwede, PhD, MPH, RN, FAAN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Nieto</last_name>
    <phone>813-745-2842</phone>
    <email>Maria.P.Nieto@moffitt.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Nieto</last_name>
      <phone>813-745-2842</phone>
      <email>Maria.P.Nieto@moffitt.org</email>
    </contact>
    <investigator>
      <last_name>Shannon M Christy, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clement K Gwede, PhD, MPH, RN, FAAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margaret M Byrne, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan T Vadaparamil, PhD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cathy D Meade, PhD, RN, FAAN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark S Friedman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna R Giuliano, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.moffitt.org/research--clinical-trials/clinical-trials</url>
    <description>Moffitt Cancer Center Clinical Trials website</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>HCV Screening</keyword>
  <keyword>CRC Screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

